News01/09/2026
Until Labs updates cryoprotectant discovery research
Until Labs, Inc. →Until Labs described a cryoprotectant screening pipeline combining computer simulations, machine learning, efficacy testing, permeation testing and cell-based biocompatibility assays before whole-organ assessment. The update concerns research progress rather than approved clinical formulations.